IBDEI2WE ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46225,1,3,0)
 ;;=3^Keratoconus,Right Eye
 ;;^UTILITY(U,$J,358.3,46225,1,4,0)
 ;;=4^H18.601
 ;;^UTILITY(U,$J,358.3,46225,2)
 ;;=^5005089
 ;;^UTILITY(U,$J,358.3,46226,0)
 ;;=H18.602^^176^2302^16
 ;;^UTILITY(U,$J,358.3,46226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46226,1,3,0)
 ;;=3^Keratoconus,Left Eye
 ;;^UTILITY(U,$J,358.3,46226,1,4,0)
 ;;=4^H18.602
 ;;^UTILITY(U,$J,358.3,46226,2)
 ;;=^5005090
 ;;^UTILITY(U,$J,358.3,46227,0)
 ;;=H18.423^^176^2302^17
 ;;^UTILITY(U,$J,358.3,46227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46227,1,3,0)
 ;;=3^Band Keratopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,46227,1,4,0)
 ;;=4^H18.423
 ;;^UTILITY(U,$J,358.3,46227,2)
 ;;=^5005068
 ;;^UTILITY(U,$J,358.3,46228,0)
 ;;=H16.213^^176^2302^18
 ;;^UTILITY(U,$J,358.3,46228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46228,1,3,0)
 ;;=3^Exposure Keratoconjunctivitis,Bilateral
 ;;^UTILITY(U,$J,358.3,46228,1,4,0)
 ;;=4^H16.213
 ;;^UTILITY(U,$J,358.3,46228,2)
 ;;=^5004922
 ;;^UTILITY(U,$J,358.3,46229,0)
 ;;=H18.833^^176^2302^19
 ;;^UTILITY(U,$J,358.3,46229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46229,1,3,0)
 ;;=3^Recurrent Erosion of Cornea,Bilateral
 ;;^UTILITY(U,$J,358.3,46229,1,4,0)
 ;;=4^H18.833
 ;;^UTILITY(U,$J,358.3,46229,2)
 ;;=^5005128
 ;;^UTILITY(U,$J,358.3,46230,0)
 ;;=B00.51^^176^2302^20
 ;;^UTILITY(U,$J,358.3,46230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46230,1,3,0)
 ;;=3^Herpesviral Iridocyclitis
 ;;^UTILITY(U,$J,358.3,46230,1,4,0)
 ;;=4^B00.51
 ;;^UTILITY(U,$J,358.3,46230,2)
 ;;=^5000473
 ;;^UTILITY(U,$J,358.3,46231,0)
 ;;=B00.52^^176^2302^21
 ;;^UTILITY(U,$J,358.3,46231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46231,1,3,0)
 ;;=3^Herpesviral Keratitis
 ;;^UTILITY(U,$J,358.3,46231,1,4,0)
 ;;=4^B00.52
 ;;^UTILITY(U,$J,358.3,46231,2)
 ;;=^5000474
 ;;^UTILITY(U,$J,358.3,46232,0)
 ;;=B00.59^^176^2302^22
 ;;^UTILITY(U,$J,358.3,46232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46232,1,3,0)
 ;;=3^Herpes Viral Eye Disease
 ;;^UTILITY(U,$J,358.3,46232,1,4,0)
 ;;=4^B00.59
 ;;^UTILITY(U,$J,358.3,46232,2)
 ;;=^5000476
 ;;^UTILITY(U,$J,358.3,46233,0)
 ;;=B02.39^^176^2302^23
 ;;^UTILITY(U,$J,358.3,46233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46233,1,3,0)
 ;;=3^Herpes Zoster Eye Disease
 ;;^UTILITY(U,$J,358.3,46233,1,4,0)
 ;;=4^B02.39
 ;;^UTILITY(U,$J,358.3,46233,2)
 ;;=^5000498
 ;;^UTILITY(U,$J,358.3,46234,0)
 ;;=H16.309^^176^2302^24
 ;;^UTILITY(U,$J,358.3,46234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46234,1,3,0)
 ;;=3^Interstitial Keratitis,Unspec Eye
 ;;^UTILITY(U,$J,358.3,46234,1,4,0)
 ;;=4^H16.309
 ;;^UTILITY(U,$J,358.3,46234,2)
 ;;=^5133472
 ;;^UTILITY(U,$J,358.3,46235,0)
 ;;=S05.01XA^^176^2302^25
 ;;^UTILITY(U,$J,358.3,46235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46235,1,3,0)
 ;;=3^Corneal Abrasion w/o FB,Right Eye,Init Enctr
 ;;^UTILITY(U,$J,358.3,46235,1,4,0)
 ;;=4^S05.01XA
 ;;^UTILITY(U,$J,358.3,46235,2)
 ;;=^5020579
 ;;^UTILITY(U,$J,358.3,46236,0)
 ;;=S05.02XA^^176^2302^26
 ;;^UTILITY(U,$J,358.3,46236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46236,1,3,0)
 ;;=3^Corneal Abrasion w/o FB,Left Eye,Init Enctr
 ;;^UTILITY(U,$J,358.3,46236,1,4,0)
 ;;=4^S05.02XA
 ;;^UTILITY(U,$J,358.3,46236,2)
 ;;=^5020582
 ;;^UTILITY(U,$J,358.3,46237,0)
 ;;=T15.01XA^^176^2302^27
 ;;^UTILITY(U,$J,358.3,46237,1,0)
 ;;=^358.31IA^4^2
